Journal Club

The purpose of the CSHP OB Journal Club is to foster evidence-based, timely and contextualized learning that has immediate or near-future implications on front-line practice. Journal Club is structured as a 30-60 minute facilitated discussion occuring once per month. 

Papers are disseminated by email 2-3 weeks in advance with accompanying backgrounder articles to enhance understanding of the topic where appropriate. Participation is open to all CSHP members including pharmacy leaders, pharmacists, residents/interns and students practicing in all collaborative settings including hospitals and ambulatory care. The overall atmosphere is conversational as we discuss how to approach a particular clinical problem, learn clinical pearls from each other, and share common wins and challenges in our own practices.

Papers welcomed for journal club include but are not limited to: randomized controlled trials, systematic reviews, narrative reviews, meta-analyses, cohort/case control studies, clinical guidelines, teachable moments, commentaries on clinical practice, validation studies, ISMP Canada Safety Bulletins, CJHP point/counterpoint articles and Health Canada's Health Product InfoWatch publications. CSHP members are always encouraged to suggest topics and/or articles for future journal club sessions.

For questions, comments, or to suggest future topics, please email: cshp.ob.journalclub@gmail.com

Upcoming Journal Club:​​​​

Event Date: Wednesday November 27, 2024

Event Time: 12:00 to 1:00 pm ET

Topic: Insights on Adult Learning: 9 Lessons from 9 Years of Journal Clubs

Article:

Summary: 

Vivian (Viv) Lee, Founder of the CSHP Ontario Branch Journal Club, looks forward to presenting her last session where she will reflect on insights gleaned from facilitating education for pharmacy professionals over the last 9 years. It is the hope that these insights will be interesting, relevant, and perhaps even actionable, as we all learn how we learn best, put knowledge to practice, and become more versatile clinicians. As an added bonus, the audience will be invited to comment on Journal Club topics of interest for the Ontario Branch to consider planning in the future. This session invites attendance from all pharmacy professionals and educators.

Presenters: 

  • Vivian Lee, Clinical Director Pharmacy Services, Mohawk Medbuy Corporation, Burlington ON

Register Here

2024 Journal Clubs:​​​​

January: 
Start Crafting a Prescription for Success for Older Adults with 2023 Updates to the AGS Beers and STOPP/START Criteria

February:
Why Pharmacists are Designers: A case application with bupivacaine shortages

March:
Understanding and Applying ISMP Canada's Canadian High-Alert Medication List 

April:
Applying Implementation Science for Antimicrobial Stewardship: Practical Strategies to Address Common Prescribing Challenges  

May:
Explore how research that considers sex and gender can improve health equity, safety, and efficacy of therapeutics

June:
Gut Instincts - Short-Course Antibiotics for Intraabdominal Infections

August:
Navigating Drug Shortages on a Micro and Macro Level: A Case Study of Injectable Pantoprazole

September:
Understanding, Embracing, and Cultivating Leadership Across the Pharmacy Profession: A Panel Discussion

October:
Fundamental Drug Information Skills for the Everyday Clinician: A Process Review and Case Study of the Safety of SC Diphenhydramine

 

 

November 2017

Point counterpoint: Should digoxin continue to be used for atrial fibrillation?

October 2017

Managing diabetic emergencies – ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS) and hypoglycemia. Are we using evidence-based approaches?

September 2017

Medical marijuana – what is the evidence?
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

August 2017

Idarucizumab for dabigatran reversal(REVERSE-AD trial) Part 2 – Full cohort analysis

July 2017

Tackling one piece of the opioid crisis: Opioid initiation in the ER
Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use.

June 2017

Can PPI and H2 blocker stewardship reduce the risk of clostridium difficile infections?
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.

May 2017

Are we underdosing VTE prophylaxis in our obese patients?
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.

April 2017

Teachable moments:
1) How to clarify a penicillin allergy
2) how to help patients sleep better in the hospital

March 2017

Incretin-based antihyperglycemics and acute pancreatitis: is there a link?
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

February 2017

Med Safety Blast – Health Product InfoWatch November and December 2016 issues

January 2017

Use of potentially inappropriate medications in alternate level of care (ALC) inpatients and a practical review of Beers Criteria
Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units

2023 Journal Clubs

2019 Journal Clubs

November 2019

Primary article: Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12.

Backgrounder article: Diagnosis and Management of the Antiphospholipid Syndrome.
N Engl J Med. 2018 May 24;378(21):2010-2021. doi: 10.1056/NEJMra1705454.

October 2019

2019 Annals of Oncology 30:897-907 

September 2019

Primary article: Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics
Backgrounder article: Should prolonged infusion of ß-lactams become standard of practice?

August 2019

A Painful Medication Reconciliation Mishap
Diagnosis and Pharmacotherapy of Alcohol-Use Disorder: A Review

May 2019

SLGT2 inhibitors – Are they the new class in heart failure?

April 2019

American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults – A Review of the Updates and Deprescribing

February 2019

Emerging cases in the ER: Managing Cannabinoid Hyperemesis Syndrome (CHS)

January 2019

Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthoplasty (EPCAT2)

2018 Journal Clubs

February 2018

Can DOACs be used to treat cancer-associated VTEs? A look at edoxaban.

March 2018

Understanding the why and how of obesity dosing for antibiotics: a narrative review of literature from 1966 to 2017

April 2018

Deprescribing opportunities in acute care – guidance from Choosing Wisely Canada. Part 1: Stool softeners, PPIs, benzodiazepines/sedative-hypnotics and combination ACEI/ARB therapy

May 2018

Deprescribing opportunities in acute care – guidance from Choosing Wisely Canada. Part 2: Statins, opioids, antipsychotics and antibiotics for asymptomatic bacteriuria.

June 2018

Improving the pharmacist handover process in the hospital: the I-HAPPY tool

July 2018

The revolving door of COPD exacerbations – how can we better optimize therapy before discharging the patient?

August 2018

Diluent shortages in the wake of Hurricane Maria: What can they teach us about the way we practice medicine?

September 2018

Are we ready for our next overdose patient? A discussion of recommended antidotes to be stocked in hospitals and national initiatives under development.

October 2018

Marijuana legalization on October 17: Reviewing medical marijuana therapy in acute care and considerations for unique inpatient populations.

November 2018

Who is at risk of oversedation in the hospital? Taking a closer look at the FROSH factors.

2017 Journal Clubs

November 2017

Point counterpoint: Should digoxin continue to be used for atrial fibrillation?

October 2017

Managing diabetic emergencies – ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS) and hypoglycemia. Are we using evidence-based approaches?

September 2017

Medical marijuana – what is the evidence?
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

August 2017

Idarucizumab for dabigatran reversal(REVERSE-AD trial) Part 2 – Full cohort analysis

July 2017

Tackling one piece of the opioid crisis: Opioid initiation in the ER
Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use.

June 2017

Can PPI and H2 blocker stewardship reduce the risk of clostridium difficile infections?
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.

May 2017

Are we underdosing VTE prophylaxis in our obese patients?
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.

April 2017

Teachable moments:
1) How to clarify a penicillin allergy
2) how to help patients sleep better in the hospital

March 2017

Incretin-based antihyperglycemics and acute pancreatitis: is there a link?
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

February 2017

Med Safety Blast – Health Product InfoWatch November and December 2016 issues

January 2017

Use of potentially inappropriate medications in alternate level of care (ALC) inpatients and a practical review of Beers Criteria
Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units

2016 Journal Clubs

November 2016

Using DOACs in morbid obesity – should we be worried?
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.
NOACS/DOACS: Coagulation Tests

October 2016

Triple antithrombotic therapy – are we doing it right?
Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention.

September 2016

Improving inhaler technique for hospitalized patients with COPD
Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease.

August 2016

Opioid discussions Part 2: Naloxone kits and Ontario Drug Benefit’s delisting of certain long-acting opioids
Dispensing or Selling Naloxone: Guidance
Reminder regarding Delisting of High-Strength Long-Acting Opiods under the ODB Program

July 2016

Opioid discussions Part 1: Preventing opioid overdoses in acute care
Retrospective analysis of opioid medication incidents requiring administration of naloxone.

June 2016

Idarucizumab for dabigatran reversal (REVERSE-AD trial) Part 1: Preliminary results

May 2016

Considerations for intravenous to oral antibiotic stepdown
Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

April 2016

Crediblemeds.org and assessing QT prolonging risk of drugs in context of clinical scenarios
Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.

March 2016

Subsequent entry biologics and implications on the hospital formulary
New Advances in Immunology: SEBs in Rheumatology, Dermatology, and Gastroenterology

Febraury 2016

Toujeo vs. Lantus in glycemic control and weight gain
Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes.